CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients

BACKGROUND: Although antibody-mediated immune responses are considered pathogenic and responsible for neural injury in anti-leucine-rich glioma-inactivated protein 1 (anti-LGI1) encephalitis, previous studies have indicated that cytokines and chemokines might play roles in the pathogenic process by...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, You-ting, Yang, Xue, Lv, Jing-wei, Liu, Xue-wu, Wang, Sheng-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792990/
https://www.ncbi.nlm.nih.gov/pubmed/31632040
http://dx.doi.org/10.2147/NDT.S222258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792990/
https://www.ncbi.nlm.nih.gov/pubmed/31632040
http://dx.doi.org/10.2147/NDT.S222258

Ejemplares similares